Back to search

Article

Beyond Mutation Count: Trinucleotide Spectrum Quality Stratifies Microsatellite-Stable Cancers Across Three Tumor Types

2026-07-30

Abstract excerpt

Microsatellite-stable (MSS) cancers comprise ~70% of patients but lack biomarkers to guide prognosis or therapy. Current metrics—TMB, CNV, and MSI—measure genomic instability quantity but discard sequence-context information encoding repair pathway activity. We developed the Trinucleotide Mutation Spectrum (TMS), a metric of mutation spectrum quality based on the proportional distribution of mutations across 192 t...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
32e3dcac-d2d4-5183-aeca-022da948237e
DOI
10.20944/preprints202607.2203.v1
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Beyond Mutation Count: Trinucleotide Spectrum Quality Stratifies Microsatellite-Stable Cancers Across Three Tumor TypesDOI 10.20944/preprints202607.2203.v1
Select a neighboring publication to make it the new centre.